Ono Pharma Establishes 10 Billion Yen Reinsurance Unit in Hawaii, Expands Global Presence.
ByAinvest
Friday, Aug 1, 2025 12:56 am ET1min read
VRTX--
Ono Pharmaceutical is establishing a 10 billion yen reinsurance unit, Ono Global Reinsurance, in Hawaii. The unit will provide reinsurance services for Ono Pharmaceutical's insurance business. The company is also expanding its drug development and commercialization efforts with a strategic agreement with Vertex Pharmaceuticals to develop and commercialize Povetacicept in Japan and South Korea. Ono Pharmaceutical has also reported positive results from a pivotal trial in US patients with relapsed or refractory PCNSL.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet